CDC Safety Group Says There’s a Likely Link Between Rare Hea
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
A CDC safety group said there’s a likely association between a rare heart inflammatory condition in adolescents and young adults mostly after they’ve received their second Covid-19 vaccine shot. There have been more than 1,200 cases of a myocarditis or pericarditis mostly in people 30 and under who received Pfizer’s or Moderna’s Covid vaccine.

Myocarditis is the inflammation of the heart muscle, while pericarditis is the inflammation of the membrane surrounding the heart. The agency said there have been 267 cases of myocarditis or pericarditis reported after receiving one dose of the mRNA vaccines and 827 reported cases after two doses through June 11. There are 132 additional cases where the number of doses received is unknown, the CDC said.

Men under 30 make up the bulk of the cases, the CDC said, and most cases appear to be mild. Of the 295 people who have developed the condition and have been discharged, 79% of them have fully recovered, according to the presentation. Nine people were hospitalized, with two in intensive care as of June 11, according to the agency.

While older age groups have seen hospitalization rates fall, they’ve barely budged among adolescents and young adults, said the CDC’s Dr. Megan Wallace. “Adolescents and young adults make up a greater proportion of total cases; 33% of cases reported in May were in persons aged 12 to 29 years, compared with 28% last December,” she said.

The CDC is coordinating its investigation with the Food and Drug Administration, which last month authorized the Pfizer-BioNTech vaccine for adolescents ages 12 to 15. Symptoms, which include chest pain and shortness of breath, typically develop within a week of receiving the shot with most developing within four days, the agency said.

Source:
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/myocarditis.html
L●●●●●a J●a and 1 others like this1 share
Like
Comment
Share